Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,819,638
-
Total 13F shares
-
4,504,385
-
Share change
-
+2,795,000
-
Total reported value
-
$9,489,895
-
Price per share
-
$2.11
-
Number of holders
-
27
-
Value change
-
+$5,791,733
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q2 2022
As of 30 Jun 2022 COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,504,385 shares of stock of the company.
Largest 10 holders included PATHSTONE FAMILY OFFICE, LLC, Voss Capital, LLC, AIGH Capital Management LLC, Worth Venture Partners, LLC, COMMONWEALTH EQUITY SERVICES, LLC, AMERICAN FINANCIAL GROUP INC, Nantahala Capital Management, LLC, P.A.W. CAPITAL CORP, Perigon Wealth Management, LLC, and Prosight Management, LP.
This table shows 27 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.